Four years ago, May 28, 2019, the patient had her first craniotomy to remove a large brain tumor in her right frontal lobe. After surgery the tumor was confirmed as a Grade IV Glioblastoma. Shortly thereafter she had a surprise second craniotomy for an infection, complete with severe pain from post herpetic neuralgia, a blood clot, lymphedema, not to mention six weeks of daily radiation and chemotherapy.
She had her first infusion of the “immunotherapy drug” (Pembrolizumab or Placebo) 14 days before her surgery on June 7, 2021. About a month after surgery she received three doses of the vaccine DCVax-L across 6 weeks.
On May 28, 2021 she wrote:
“I'm still in shock that this is happening again and so relieved that I was able to be given the LAST SPOT in the clinical trial, which I hope will lead to a cure for Glioblastoma.”
Hard to know what “last spot” means. I think she was the last patient who could be enrolled before the summer holidays. If my reasoning is correct, this patient is censored between 410 - 420 days after surgery on the blue line. My guess is the data were collected at the end of July - first week of August 2022.